ReviewAnaemia in the elderlyLa anemia del anciano☆
Introduction
The average life expectancy has increased drastically over the last century (from ≈60 years in 1900 to ≈80 years in 2015) and is estimated to increase further in the future.1 In the European Union, the proportion of individuals ≥80 years will triple between 2011 and 2060.2 With age there is an inevitable deterioration of the organic functionality (ageing) that eventually leads to death. Age is also a risk factor for common processes, whether diagnosed or not, such as cardiovascular disease, cancer, diabetes or Alzheimer's disease, which increase the risk of mortality.1
Factors responsible for the phenotypic changes leading to the loss of physiological reserve, organic failure and reduction of the functionality have a role in the ageing process. The sum of these factors would give rise to the clinical features in the elderly: frailty, anaemia, malnutrition and poor immune response.1 Whether anaemia is an independent risk factor for functional impairment, a surrogate marker of a worse health status or simply an additional comorbidity, is something that we still do not know.
A better understanding of the molecular basis of ageing would facilitate the development of interventions that, if applied early, could prevent, delay, alleviate or even reverse some of the diseases related to ageing, thereby gaining years of independent living. That is, we would not only add “years to life”, but also “life to years”.
Section snippets
Definition and prevalence of anaemia in the elderly
According to the World Health Organization (WHO), the concentration of haemoglobin (Hb) that defines the presence of anaemia in the elderly would be <13 g/dl in men and <12 g/dl in women.3 With these definitions, between 1993 and 2005 anaemia affected 24% of the world's elderly (164 million individuals), although with important regional differences.4 However, there are authors who question its validity in the elderly, in whom an Hb value near the lower limit of normality could be associated with
Consequences of anaemia in the elderly
Anaemia reduces physical capacity and muscle strength in the elderly, decreasing mobility and quality of life.16 In addition, it increases the risk of fatigue, depression, dementia, hospitalization (due to exacerbations of intercurrent disease, falls) or admission to nursing homes (due to exacerbation of functional deterioration) and mortality (especially if accompanied by other disorders such as heart or kidney failure, high blood pressure or diabetes).17, 18 In a meta-analysis of 24 studies
Causes of anaemia in the elderly
Anaemia in the elderly usually has a multifactorial origin; all pathophysiological mechanisms are possible and many of them are simultaneous. In the NAHNES III study, nutritional deficiencies were responsible for 34% of the cases, while chronic diseases, with and without renal failure, accounted for another 33%.7 In 33% of cases, it was not possible to identify the aetiology (unexplained anaemia in the elderly [UAE]).7 The high prevalence of UAE (25–45%) in large epidemiological studies on
Diagnosis of anaemia in the elderly
Anaemia in the elderly is usually mild-moderate and the onset of symptoms is insidious, so its clinical symptoms are not normally very helpful for diagnosis. Decreased physical activity, fatigue, weakness and dyspnoea can be attributed to the ageing process or the worsening of intercurrent diseases; not so the pallor reflected by low levels of Hb (<9 g/dl). It is often a casual finding in laboratory tests requested for any other cause (e.g., preoperative laboratory tests, health examinations).
Treatment of anaemia in the elderly
Healthy elderly do not have to suffer anaemia, rather, they should have levels that are close to the lower limit of normal. Therefore, it is very common for anaemia to be of mixed aetiology, depending on the comorbidities, and its treatment must be etiological (or, failing that, pathophysiological). Iron and maturation factor supplementation and erythropoiesis stimulating agents (ESA) form the basis of treatment, together with that of the underlying disease, with red blood cell transfusion
Conclusions
- •
Anaemia in the elderly is common, increases with age and is an independent risk factor for greater morbidity and mortality in this population.
- •
There is no consensus on the level of Hb that defines the presence of anaemia in the elderly, nor on what is the “healthy level of Hb” in these individuals, according to their age and comorbidity.
- •
The correct classification of anaemia in the elderly can be complicated due to the presence of multiple comorbidities, it requires persistence and yet it is not
Conflict of interest
The authors declare no conflict of interest.
References (60)
- et al.
Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia
Blood
(2004) - et al.
Food-cobalamin malabsorption and vitamin B12 deficiency in adults and in elderly patients: what is the problem
Rev Med Interne
(2016) - et al.
The active role of vitamin C in mammalian iron metabolism: much more than just enhanced iron absorption!
Free Radic Biol Med
(2014) Anemia of chronic disorders: new diagnostic tools and new treatment strategies
Semin Hematol
(2015)Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
Blood
(2015)- et al.
Unexplained anemia in the elderly
Semin Hematol
(2008) - et al.
Proinflammatory state, hepcidin, and anemia in older persons
Blood
(2010) - et al.
Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women
Blood
(2015) - et al.
Are we giving too much iron? Low-dose iron therapy is effective in octogenarians
Am J Med
(2005) - et al.
‘Fit to fly’: overcoming barriers to preoperative haemoglobin optimization in surgical patients
Br J Anaesth
(2015)
Foro de debate: Seguridad de las alternativas a la transfusión alogénica en el paciente quirúrgico y/o crítico
Med Intensiva
Molecular and biological hallmarks of ageing
Br J Surg
Age and aging in blood disorders: EHA theme of the year 2013–2014
Haematologica
Worldwide prevalence of anaemia report 1993–2005. WHO global database on anaemia
What constitutes normal hemoglobin concentration in community-dwelling disabled older women
J Am Geriatr Soc
Prevalence of anemia and iron deficiency in older Portuguese adults: an EMPIRE substudy
Geriatr Gerontol Int
Incidence of anemia in older people: an epidemiologic study in a well-defined population
J Am Geriatr Soc
Prevalence, incidence and types of mild anemia in the elderly: the health and anemia population-based study
Haematologica
Prevalence of anaemia in older persons: systematic review
BMC Geriatr
Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study
J Am Geriatr Soc
Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery
JAMA
Pre-operative haemoglobin levels and iron status in a large multicentre cohort of patients undergoing major elective surgery
Anaesthesia
Prevalence and severity of anaemia among medical patients from different hospital departments
Transfus Altern Transfus Med
Anemia is associated with disability and decreased physical performance and muscle strength in the elderly
J Am Geriatr Soc
Anemia in the elderly: clinical implications and new therapeutic concepts
Haematologica
Anemia and mortality in older persons: does the type of anemia affect survival?
Int J Hematol
Meta-analysis of the association between preoperative anaemia and mortality after surgery
Br J Surg
Non-anaemic iron deficiency — a disease looking for recognition of diagnosis: a systematic review
Eur J Haematol
Cited by (0)
- ☆
Please cite this article as: Gómez Ramírez S, Remacha Sevilla ÁF, Muñoz Gómez M. La anemia del anciano. Med Clin (Barc). 2017;149:496–503.